Cancer Genomics Clinical Trials Fund: SCCT Program
Overview
The Cancer Genomics Clinical Trials Fund (the Fund) is a one-off grant opportunity that will run over three years, FY2025-26 through to FY2027-28. The Fund will direct additional investment to Australia's Multi-site Collaborative Cancer Clinical Trials Groups (CTGs) under the Support for Cancer Clinical Trials (SCCT) program to build capacity and develop approached of methods to set the foundation for, and accelerate the incorporation of genomics into the design of cancer clinical trial concepts and protocols to benefit all CTGs. For further information please refer to the Cancer Genomics Clinical Trials Fund Grant Opportunity Guidelines.
Key Information
AustraliaDetails
- Lead OrganisationCTGs must appoint a single 'lead organisation' to submit the application and enter into a grant agreement with the Commonwealth.
- Consortium MembersAll participating organisations must be eligible as identified under Section 4.1 of the Guidelines and must have formal arrangements in place prior to the execution of a grant agreement.
- Contact
- SCCT@canceraustralia.gov.au
- •Only a single lead organisation can submit the application and enter into a grant agreement.
Supporting Documents
Sign in to download documents
Chat with Documents
AI PreviewSign in to chat with grant documents and get instant answers
Similar Opportunities
Sign up to get deadline reminders, save opportunities, and manage your applications in one place.
Start Free TrialSign InAI-generated proposal writing guide with win themes, timeline and risk register.
Sign In to Generate PlanPredict your likelihood of winning with an AI-powered success score and recommendations.
Sign In to View Score